المؤلفون: Moura DS; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Peña-Chilet M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Seville, Spain., Cordero Varela JA; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Alvarez-Alegret R; Pathology Department, Miguel Servet University Hospital, Zaragoza, Spain., Agra-Pujol C; Pathology Department, Gregorio Marañon University Hospital, Madrid, Spain., Izquierdo F; Pathological Anatomy Service, Complejo Asistencial Universitario de León, Spain., Ramos R; Pathology Department, Son Espases University Hospital, Mallorca, Spain., Ortega-Medina L; Pathology Department, Hospital Clinico San Carlos, Madrid, Spain., Martin-Davila F; Pathology Department, Ciudad Real General Hospital, Spain., Castilla-Ramirez C; Pathology Department, University Hospital Virgen del Rocio, Seville, Spain., Hernandez-Leon CN; Pathology Department, Canarias University Hospital, Santa Cruz de Tenerife, Spain., Romagosa C; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Vaz Salgado MA; Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain., Lavernia J; Medical Oncology Department, Instituto Valenciano de Oncologia, Valencia, Spain., Bagué S; Pathology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Mayodormo-Aranda E; Pathology Department, Hospital Universitari i Politècnic la Fe, Valencia, Spain., Vicioso L; Pathology Department, Virgen de la Victoria University Hospital, Malaga, Spain., Hernández Barceló JE; Pathology Department, Virgen de la Arrixaca University Hospital, Murcia, Spain., Rubio-Casadevall J; Medical Oncology Department, Hospital Josep Trueta, Catalan Institute of Oncology, Girona, Spain., de Juan A; Medical Oncology Department, Marqués de Valdecilla University Hospital, Santander, Spain., Fiaño-Valverde MC; Department of Histopathology, Álvaro Cunqueiro Hospital, University Hospital Complex of Vigo, Spain., Hindi N; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain., Lopez-Alvarez M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Lacerenza S; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Dopazo J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Seville, Spain.; INB-ELIXIR-es, FPS, Hospital Virgen del Rocío, Seville, Spain., Gutierrez A; Hematology Department, Son Espases University Hospital, Mallorca, Spain., Alvarez R; Medical Oncology Department, Gregorio Marañon University Hospital, Madrid, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Martinez-Trufero J; Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain., Martín-Broto J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain.

المصدر: Molecular oncology [Mol Oncol] 2021 Dec; Vol. 15 (12), pp. 3691-3705. Date of Electronic Publication: 2021 Jun 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/drug therapy , Sarcoma*/genetics , Tetrahydroisoquinolines*/adverse effects, Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; DNA Damage ; DNA Repair/genetics ; Dioxoles/adverse effects ; Humans ; Retrospective Studies ; Trabectedin/therapeutic use